Please login to the form below

Not currently logged in
Email:
Password:

cholesterol

This page shows the latest cholesterol news and features for those working in and with pharma, biotech and healthcare.

Better times ahead, promises AZ as Crestor drop outweighs new drugs

Better times ahead, promises AZ as Crestor drop outweighs new drugs

s cholesterol drug Crestor – pegging back sales and earnings in the first quarter.

Latest news

More from news
Approximately 26 fully matching, plus 485 partially matching documents found.

Latest Intelligence

  • Tools for the digital world Tools for the digital world

    One study showed that patients with uncontrolled hypertension and diabetes achieved significantly greater reduction in blood pressure (BP) and LDL cholesterol, and were more likely to reach their BP goal, than

  • Challenging times Challenging times

    continents. We surveyed 21, 300 research participants with a range of chronic diseases including but not limited to high blood pressure, high cholesterol, diabetes, asthma, heart conditions and cancer.

  • Pharma deals in September 2015 Pharma deals in September 2015

    Amgen's busy month (part 2). Following FDA approval for its novel PCSK9 treatment for “ bad cholesterol”, Amgen is moving onto tackle dyslipidemia, an asymptomatic disease in which serum lipid levels ... Dezima's TA-8995 (phase 2b-complete), is an

  • Community pharmacy and OTC healthcare Community pharmacy and OTC healthcare

    Pharmacists' wellness and prevention role means intervening when people are still well and many provide services such as weight management, smoking cessation and cholesterol and blood pressure monitoring.

  • Pharma deals during November 2014 Pharma deals during November 2014

    In July, BioMarin sold its PRV to Regeneron for $68m to expedite filing of its cholesterol drug, the PCSK9 inhibitor alirocumab, being developed in partnership with Sanofi.

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics